Early maternal tenofovir treatment and infant vaccination: a scalable model for hepatitis B virus mother-to-child transmission control in resource-limited areas
- PMID: 41221138
- PMCID: PMC12598244
- DOI: 10.21037/tgh-25-59
Early maternal tenofovir treatment and infant vaccination: a scalable model for hepatitis B virus mother-to-child transmission control in resource-limited areas
Keywords: Hepatitis B virus (HBV); hepatitis B immunoglobulin (HBIG); mother-to-child transmission (MTCT); resource-limited settings (RLS); tenofovir disoproxil fumarate (TDF).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tgh.amegroups.com/article/view/10.21037/tgh-25-59/coif). C.S.C. reports fees for consulting and research grants paid to the University of Calgary. The other author has no conflicts of interest to declare.
Comment on
-
Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial.JAMA. 2025 Feb 4;333(5):390-399. doi: 10.1001/jama.2024.22952. JAMA. 2025. PMID: 39540799 Free PMC article. Clinical Trial.
References
-
- World Health Organization. Hepatitis B. 2024. Retrieved on April 25, 2025. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
Publication types
LinkOut - more resources
Full Text Sources